(Q41692610)
Statements
1 reference
Treatment of poor prognosis AML patients using PSC833 (valspodar) plus mitoxantrone, etoposide, and cytarabine (PSC-MEC). (English)
1 reference
E Paietta
1 reference
P H Wiernik
1 reference
B Sikic
1 reference
R Advani
1 reference
G Visani
1 reference
D Milligan
1 reference
H Saba
1 reference
M Tallman
1 reference
J M Rowe
1 reference
J Ramek
1 reference
K Dugan
1 reference
B Lum
1 reference
J Villena
1 reference
E Davis
1 reference
M Litchman
1 reference
A Covelli
1 reference
P Greenberg
1 reference
1 January 1999
1 reference
1 reference
457
1 reference
47-56
1 reference
Identifiers
1 reference